Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal alveolar concentration of sevoflurane and isoflurane in patients with hepatic injury
ChiCTR-TRC-11001507Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2011
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and isoflurane in Hepatic injury (not a disease, but a descriptive term for liver damage) (6 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Met-enkephalin, MAC of sevoflurane and isoflurane at BIS 50 and 1 more. Started Sep 2011; status: completed.
02
Drugs
sevofluraneisoflurane
03
Conditions
Hepatic injury (not a disease, but a descriptive term for liver damage)
Beyond the preview
Go deeper on ChiCTR-TRC-11001507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001507.